Literature DB >> 28697967

"New" bronchopulmonary dysplasia and chronic lung disease.

Judith A Voynow1.   

Abstract

Bronchopulmonary dysplasia (BPD) is the major cause of chronic lung disease and morbidity in preterm infants. Since it was first described fifty years ago, the epidemiology, pathogenesis, and treatment for BPD has changed dramatically. This review summarizes these changes and the clinical outcomes for infants diagnosed with BPD.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Glucocorticoids; Oxygenation; Preterm infants; Surfactant; Ventilation

Mesh：

Substances：

Year:  2017        PMID： 28697967     DOI： 10.1016/j.prrv.2017.06.006

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN： 1526-0542            Impact factor:   2.726


  23 in total

1.  Fatty Acid Oxidation Protects against Hyperoxia-induced Endothelial Cell Apoptosis and Lung Injury in Neonatal Mice.

Authors:  Hongwei Yao; Jiannan Gong; Abigail L Peterson; Xuexin Lu; Peng Zhang; Phyllis A Dennery
Journal:  Am J Respir Cell Mol Biol       Date:  2019-06       Impact factor: 6.914

Review 2.  New-generation intravenous fat emulsions and bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis.

Authors:  Xue Fan; Ying Tang; Jun Tang; Juan Chen; Jing Shi; Hua Wang; Bin Xia; Yi Qu; Dezhi Mu
Journal:  J Perinatol       Date:  2020-07-07       Impact factor: 2.521

3.  A Shared Pattern of β-Catenin Activation in Bronchopulmonary Dysplasia and Idiopathic Pulmonary Fibrosis.

Authors:  Jennifer M S Sucre; Gail H Deutsch; Christopher S Jetter; Namasivayam Ambalavanan; John T Benjamin; Linda A Gleaves; Bryan A Millis; Lisa R Young; Timothy S Blackwell; Jonathan A Kropski; Susan H Guttentag
Journal:  Am J Pathol       Date:  2018-01-31       Impact factor: 4.307

4.  A novel approach using volumetric dynamic airway computed tomography to determine positive end-expiratory pressure (PEEP) settings to maintain airway patency in ventilated infants with bronchopulmonary dysplasia.

Authors:  Lauren A May; Siddharth P Jadhav; R Paul Guillerman; Pamela D Ketwaroo; Prakash Masand; Melissa M Carbajal; Rajesh Krishnamurthy
Journal:  Pediatr Radiol       Date:  2019-07-16

5.  Placental proteins with predicted roles in fetal development decrease in premature infants.

Authors:  Cynthia Schreiner; Theresa L Powell; Claire Palmer; Thomas Jansson
Journal:  Pediatr Res       Date:  2022-02-07       Impact factor: 3.953

6.  Identification of a FGF18-expressing alveolar myofibroblast that is developmentally cleared during alveologenesis.

Authors:  Andrew S Hagan; Bo Zhang; David M Ornitz
Journal:  Development       Date:  2020-01-17       Impact factor: 6.868

7.  Bronchopulmonary dysplasia patients have preserved CT-measured central airway luminal area.

Authors:  Winston L Guo; Ilhan M Eli; Juan G Ripoll; Sarah E Baker; John R A Shepherd; Chad C Wiggins; Brian T Welch; Michael J Joyner; Paolo B Dominelli
Journal:  Respir Med       Date:  2020-06-25       Impact factor: 3.415

8.  Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants.

Authors:  Xueyu Chen; Huitao Li; Xiaomei Qiu; Chuanzhong Yang; Frans J Walther
Journal:  BMC Pediatr       Date:  2019-04-30       Impact factor: 2.125

Review 9.  Melatonin as a master regulator of cell death and inflammation: molecular mechanisms and clinical implications for newborn care.

Authors:  Anna Tarocco; Natascia Caroccia; Giampaolo Morciano; Mariusz R Wieckowski; Gina Ancora; Giampaolo Garani; Paolo Pinton
Journal:  Cell Death Dis       Date:  2019-04-08       Impact factor: 8.469

10.  Hospitalizations for viral respiratory infections in children under 2 years of age: epidemiology and in-hospital complications.

Authors:  Jessie N Zurita-Cruz; Alejandro Gutierrez-Gonzalez; Leticia Manuel-Apolinar; José Esteban Fernández-Gárate; María Luisa Arellano-Flores; Roberto Alejandro Correa Gonzalez; Guillermo Vázquez-Rosales; Rocio Sanchez-Armas; Nelly Cisneros-González
Journal:  BMC Pediatr       Date:  2020-06-09       Impact factor: 2.125
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.